TransCode Therapeutics Inc. Recorded Big Gain
Fri, Jan 24, 2025 at 07:19 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) jumped higher at $7.04, a gain of 82%. On Fri, Jan 24, 2025, RNAZ:NASDAQ touched a New 2-Week High of $7.04. The stock appeared on our News Catalysts scanner on Tue, Jan 14, 2025 at 09:25 AM in the 'BIOTECH' category. From Fri, Jan 10, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Thu, Jan 23, 2025 at $12.43 with a volume of 10M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Canoo Inc. (GOEV:NASDAQ), 2183.65%
- 111, Inc. (YI:NASDAQ), 1578.32%
- Evaxion Biotech A/S (EVAX:NASDAQ), 773.91%
- Nvni Group Limited (NVNI:NASDAQ), 623.81%
- Neuphoria Therapeutics Inc. (NEUP:NASDAQ), 415.83%
- Elevai Labs Inc. (ELAB:NASDAQ), 273.49%
- Allurion Technologies Inc. (ALUR:NYSE), 134.86%
- Aclarion Inc. (ACON:NASDAQ), 104.09%
- PicoCELA Inc. (PCLA:NASDAQ), 104.04%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 81.98%